TRVI News
Archived Headlines
- US IPO Week Ahead: Plant burgers go public in a 7-IPO week 04/26/19
- TPG-backed biotech Trevi Therapeutics sets terms for $70 million IPO 04/22/19
- US IPO Week Ahead: No IPOs but these 12 deals can hop back in after Easter 04/18/19
- Neurological disorder biotech Trevi Therapeutics files for an $86 million IPO 04/05/19
US IPO Weekly Recap: Uber falls 8% in a disappointing debut
Ridesharing giant Uber (UBER) made its debut this week, raising $8.1 billion dollars at a market cap of $82 billion, making it the largest US IPO since Alibaba went public in 2014. Uber priced its IPO at $45, 4% below the midpoint of the $44...read more
Trevi Therapeutics prices IPO at $10, the downwardly revised price
Trevi Therapeutics, which is developing an extended-release version of an opioid for new indications, raised $55 million by offering 5.5 million shares at $10, the downwardly revised price. Trevi Therapeutics plans to list on the Nasdaq under the symbol...read more
Trevi Therapeutics decreases proposed IPO deal size by 21%
Trevi Therapeutics, which is developing an extended-release version of an opioid for new indications, lowered the proposed deal size for its upcoming IPO on Monday. The New Haven, CT-based company now plans to raise $55 million by offering 5.5 million...read more
US IPO Week Ahead: It's Uber uber alles with biggest IPO in 5 years
If 2019 is indeed the "year of Uber," then the week ahead can only be the "week of Uber." After years of IPO speculation, Uber (UBER) is expected to raise $8.5 billion at the $47 midpoint, with insiders selling $1.3 billion in the...read more